对《莱姆病螺旋体病治疗后持续症状的患病率：一项前瞻性观察队列研究》[《柳叶刀区域健康 - 欧洲》6（2021）100142]的更正
Corrections to "Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study" [The Lancet Regional Health - Europe 6 (2021) 100142].
作者信息
Ursinus Jeanine, Vrijmoeth Hedwig D, Harms Margriet G, Tulen Anna D, Knoop Hans, Gauw Stefanie A, Zomer Tizza P, Wong Albert, Friesema Ingrid H M, Vermeeren Yolande M, Joosten Leo A B, Hovius Joppe W, Kullberg Bart Jan, van den Wijngaard Cees C
机构信息
Department of Internal Medicine, Division of Infectious Diseases & Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, P.O. Box 22660, 1100 DD, Amsterdam, Netherlands.
Department of Internal Medicine and Radboudumc Center for Infectious Diseases (RCI), Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, Netherlands.
出版信息
Lancet Reg Health Eur. 2023 Mar 15;27:100622. doi: 10.1016/j.lanepe.2023.100622. eCollection 2023 Apr.
Abstract
[This corrects the article DOI: 10.1016/j.lanepe.2021.100142.].
摘要
[本文更正了文章的数字对象标识符：10.1016/j.lanepe.2021.100142。]
相似文献
1
Corrections to "Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study" [The Lancet Regional Health - Europe 6 (2021) 100142].对《莱姆病螺旋体病治疗后持续症状的患病率：一项前瞻性观察队列研究》[《柳叶刀区域健康 - 欧洲》6（2021）100142]的更正
Lancet Reg Health Eur. 2023 Mar 15;27:100622. doi: 10.1016/j.lanepe.2023.100622. eCollection 2023 Apr.
2
Correction to "Concerns about the external validity of the study 'prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study'-authors' reply".对《莱姆病治疗后持续症状的患病率：一项前瞻性观察队列研究》的关注——作者回复的勘误
Lancet Reg Health Eur. 2022 Jul 22;19:100449. doi: 10.1016/j.lanepe.2022.100449. eCollection 2022 Aug.
3
Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).治疗莱姆病后持续性症状的患病率及其决定因素：一项观察性、前瞻性队列研究（LymeProspect）的研究方案。
BMC Infect Dis. 2019 Apr 15;19(1):324. doi: 10.1186/s12879-019-3949-8.
4
Corrigendum to 'Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study' [The Lancet Regional Health - Europe 35 (2023) 100747].《“奥密克戎时代COVID-19对免疫功能低下人群的影响：基于人群的观察性INFORM研究的见解”的勘误》[《柳叶刀区域健康 - 欧洲》35卷（2023年）100747]
Lancet Reg Health Eur. 2024 Jul 25;44:101008. doi: 10.1016/j.lanepe.2024.101008. eCollection 2024 Sep.
5
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912].《意大利肿瘤药物监测登记处与临床试验中患者基线特征的比较：一项真实世界横断面研究》的勘误 [《柳叶刀区域健康 - 欧洲》41 (2024) 100912]
Lancet Reg Health Eur. 2024 May 21;42:100940. doi: 10.1016/j.lanepe.2024.100940. eCollection 2024 Jul.
6
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912].《意大利肿瘤药物监测登记与临床试验中患者基线特征的比较：一项真实世界横断面研究》勘误 [《柳叶刀区域健康 - 欧洲》41 (2024) 100912]
Lancet Reg Health Eur. 2024 Jun 24;42:100973. doi: 10.1016/j.lanepe.2024.100973. eCollection 2024 Jul.
7
Corrigendum to "Risk of cancer in young and older patients with congenital heart disease and the excess risk of cancer by syndromes, organ transplantation and cardiac surgery: Swedish health registry study (1930-2017)" [The Lancet Regional Health-Europe 18 (2022) 100407].《先天性心脏病年轻和老年患者的癌症风险以及综合征、器官移植和心脏手术导致的额外癌症风险：瑞典健康登记研究（1930 - 2017年）》勘误 [《柳叶刀区域健康 - 欧洲》18 (2022) 100407]
Lancet Reg Health Eur. 2024 Apr 16;40:100911. doi: 10.1016/j.lanepe.2024.100911. eCollection 2024 May.
8
Corrigendum to "Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)" [The Lancet Regional Health - Europe 40 (2024) 100892].《欧洲先天性感染倡议组织（ECCI）关于先天性巨细胞病毒感染的产前、新生儿期及产后管理的共识推荐》勘误 [《柳叶刀区域健康——欧洲》40（2024）100892]
Lancet Reg Health Eur. 2024 Jun 24;42:100974. doi: 10.1016/j.lanepe.2024.100974. eCollection 2024 Jul.
9
Correction to "Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination" [The Lancet Regional Health - Europe 38 (2024) 100829].对《保护婴儿免受呼吸道合胞病毒疾病侵害：长效单克隆抗体与母体疫苗接种的影响及成本效益比较》的勘误 [《柳叶刀区域健康——欧洲》38 (2024) 100829]
Lancet Reg Health Eur. 2024 Sep 11;45:101073. doi: 10.1016/j.lanepe.2024.101073. eCollection 2024 Oct.
10
Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis.欧洲持续性莱姆病经验性抗生素研究（PLEASE）——一项针对归因于莱姆病螺旋体病的持续性症状患者进行延长抗生素治疗的随机对照试验的设计
BMC Infect Dis. 2014 Oct 16;14:543. doi: 10.1186/s12879-014-0543-y.
Zotero 插件